• About us
• Contact Info
• Key persons
• • Management
  • Board of directors
  • Scientific advisory board
• IPR
• Products
• Careers

NEXT Biomed is committed in having strong emphasis on an active patenting policy in protecting its innovations.

The IPR portfolio of NEXT Biomed consists of several issued patents and patent applications in the USA, Finland and in other countries related to HIV diagnostics and development of bioengineered ligand-binding polypeptides.

In addition, NEXT Biomed has licensed new technologies providing scientific and business synergy with the IPR development by its own R&D activities.